219 related articles for article (PubMed ID: 20679134)
1. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
Reed JR; Huber WJ; Backes WL
Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
[TBL] [Abstract][Full Text] [Related]
2. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
[TBL] [Abstract][Full Text] [Related]
3. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A
J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037
[TBL] [Abstract][Full Text] [Related]
4. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.
Miralem T; Hu Z; Torno MD; Lelli KM; Maines MD
J Biol Chem; 2005 Apr; 280(17):17084-92. PubMed ID: 15741166
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Understanding of the Reaction Chemistries of the Heme Catabolizing Enzymes HO and BVR Based on High Resolution Protein Structures.
Sugishima M; Wada K; Fukuyama K
Curr Med Chem; 2020; 27(21):3499-3518. PubMed ID: 30556496
[TBL] [Abstract][Full Text] [Related]
6. Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.
Marohnic CC; Huber Iii WJ; Patrick Connick J; Reed JR; McCammon K; Panda SP; Martásek P; Backes WL; Masters BS
Arch Biochem Biophys; 2011 Sep; 513(1):42-50. PubMed ID: 21741353
[TBL] [Abstract][Full Text] [Related]
7. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.
Barone E; Di Domenico F; Mancuso C; Butterfield DA
Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978
[TBL] [Abstract][Full Text] [Related]
8. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.
Maghzal GJ; Leck MC; Collinson E; Li C; Stocker R
J Biol Chem; 2009 Oct; 284(43):29251-9. PubMed ID: 19690164
[TBL] [Abstract][Full Text] [Related]
9. Biliverdin as a disease-modifying agent: An integrated viewpoint.
Mancuso C
Free Radic Biol Med; 2023 Oct; 207():133-143. PubMed ID: 37459935
[TBL] [Abstract][Full Text] [Related]
10. Measurement of membrane-bound human heme oxygenase-1 activity using a chemically defined assay system.
Huber WJ; Marohnic CC; Peters M; Alam J; Reed JR; Masters BS; Backes WL
Drug Metab Dispos; 2009 Apr; 37(4):857-64. PubMed ID: 19131520
[TBL] [Abstract][Full Text] [Related]
11. The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.
Ding B; Gibbs PE; Brookes PS; Maines MD
FASEB J; 2011 Jan; 25(1):301-13. PubMed ID: 20876213
[TBL] [Abstract][Full Text] [Related]
12. The brain heme oxygenase/biliverdin reductase system as a target in drug research and development.
Mancuso C
Expert Opin Ther Targets; 2022 Apr; 26(4):361-374. PubMed ID: 35285395
[TBL] [Abstract][Full Text] [Related]
13. The heme oxygenase/biliverdin reductase system in skin cancers.
Arena V; Pennacchia I; Guerriero G; Mancuso C
J Biol Regul Homeost Agents; 2015; 29(1):259-64. PubMed ID: 25864768
[TBL] [Abstract][Full Text] [Related]
14. Isoporphyrin intermediate in heme oxygenase catalysis. Oxidation of alpha-meso-phenylheme.
Evans JP; Niemevz F; Buldain G; de Montellano PO
J Biol Chem; 2008 Jul; 283(28):19530-9. PubMed ID: 18487208
[TBL] [Abstract][Full Text] [Related]
15. The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase. Electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN.
Higashimoto Y; Sato H; Sakamoto H; Takahashi K; Palmer G; Noguchi M
J Biol Chem; 2006 Oct; 281(42):31659-67. PubMed ID: 16928691
[TBL] [Abstract][Full Text] [Related]
16. Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase.
Kutty RK; Daniel RF; Ryan DE; Levin W; Maines MD
Arch Biochem Biophys; 1988 Feb; 260(2):638-44. PubMed ID: 3124760
[TBL] [Abstract][Full Text] [Related]
17. Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes.
Rochette L; Zeller M; Cottin Y; Vergely C
Trends Endocrinol Metab; 2018 Feb; 29(2):74-85. PubMed ID: 29249571
[TBL] [Abstract][Full Text] [Related]
18. Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance.
Florczyk UM; Jozkowicz A; Dulak J
Pharmacol Rep; 2008; 60(1):38-48. PubMed ID: 18276984
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells.
Young SC; Storm MV; Speed JS; Kelsen S; Tiller CV; Vera T; Drummond HA; Stec DE
Am J Physiol Regul Integr Comp Physiol; 2009 Nov; 297(5):R1546-53. PubMed ID: 19759334
[TBL] [Abstract][Full Text] [Related]
20. [Structure and mechanism of heme oxygenase].
Sakamoto H; Sugishima M; Higashimoto Y; Fukuyama K; Noguchi M
Seikagaku; 2005 Jul; 77(7):634-8. PubMed ID: 16114846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
